PSUSA/00001529/202011 - periodic safety update report single assessment
Glatiramer
PSUSAHuman
On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.
Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.
Glatiramer - List of nationally authorised medicinal products - PSUSA-00001529-202011
English (EN) (262.84 KB - PDF)
Glatiramer - Scientific conclusions and grounds for the variation to the terms of the Marketing Authorisation - PSUSA-00001529-202011
English (EN) (33.83 KB - PDF)
български (BG) (80.29 KB - PDF)
español (ES) (35.56 KB - PDF)
čeština (CS) (134.01 KB - PDF)
dansk (DA) (34.48 KB - PDF)
Deutsch (DE) (155.78 KB - PDF)
eesti keel (ET) (30.2 KB - PDF)
ελληνικά (EL) (84.1 KB - PDF)
français (FR) (34.28 KB - PDF)
hrvatski (HR) (73.59 KB - PDF)
íslenska (IS) (36.15 KB - PDF)
italiano (IT) (36.54 KB - PDF)
latviešu valoda (LV) (76.32 KB - PDF)
lietuvių kalba (LT) (77.31 KB - PDF)
magyar (HU) (153.76 KB - PDF)
Malti (MT) (78.4 KB - PDF)
Nederlands (NL) (36.33 KB - PDF)
norsk (NO) (30.64 KB - PDF)
polski (PL) (80.05 KB - PDF)
português (PT) (34.25 KB - PDF)
română (RO) (66.96 KB - PDF)
slovenčina (SK) (77.46 KB - PDF)
slovenščina (SL) (66.22 KB - PDF)
Suomi (FI) (86.42 KB - PDF)
svenska (SV) (34.46 KB - PDF)